T1	intervention 31 46	Huaier granules
T2	No-of-participants 701 720	Two hundred and one
T3	eligibility 721 772	TNBC patients underwent modified radical mastectomy
T4	duration 823 861	between October 2010 to September 2014
T5	intervention-participants 927 930	101
T6	control 945 958	control group
T7	control-participants 960 963	100
T8	outcome-Measure 1260 1313	disease-free survival (DFS) and overall survival (OS)
T10	control-participants 1398 1401	100
T11	control-value 1451 1454	82%
T12	control-value 1459 1462	86%
T13	intervention-value 1483 1488	87.1%
T14	intervention-value 1493 1498	90.1%
T15	intervention-participants 1507 1510	101
T16	outcome 1655 1665	5-year DFS
T17	control-value 1669 1674	53.8%
T18	outcome 1679 1681	OS
T19	control-value 1685 1690	65.4%
T20	outcome 1606 1624	stage III patients
T21	intervention-value 1784 1789	81.3%
T22	intervention-value 1794 1799	87.5%
T23	intervention-value 1828 1830	10
T24	outcome 1871 1890	disease progression
T25	control-value 1905 1906	3
T9	outcome 1429 1439	5-year DFS
T26	outcome 1444 1446	OS
